Levetiracetam Solution
FDA Label NDC 55154-4316

41 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Levetiracetam (NDC 55154-4316). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 partial-onset seizures, 1.2 myoclonic seizures in patients with juvenile myoclonic epilepsy, 1.3 primary generalized tonic-clonic seizures, 2.1 important administration instructions, 2.2 dosing for partial-onset seizures, other, 2.3 dosing for myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy, adults 16 years of age and older, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package/Label Display Panel

NDC 55154-4316-5

LEVETIRACETAM

ORAL SOLUTION, USP

500 mg / 5 mL

5 x 5 mL UNIT DOSE CUPS

500mg/5ml Bag Label (0253fb34 3555 4f12 9442 0a9be7bb6878 00)

500mg/5ml Bag Label (0253fb34 3555 4f12 9442 0a9be7bb6878 00)

* Please review the disclaimer below.